Doctor of Dentistry Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Rushil Dang

Oral & Maxillofacial Surgery Detroit, MI Doctor of Dentistry

NPI 1346613312 CMS profile 1377869

2799 W Grand Blvd Ste 3A, Detroit, MI 48202

Open in the dashboard

General payments

$33,642

48 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Rushil Dang of Detroit, MI is reported in the CMS Open Payments database as having received $33,642 across 48 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Oral & Maxillofacial Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $641 7
2024 General $1,518 13
2022 General $11,652 9
2021 General $18,922 7
2020 General $350 3
2019 General $559 9

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Rushil Dang
  • Oral & Maxillofacial Surgery median
  • Middle half of Oral & Maxillofacial Surgery
  • National median

In program year 2025, general payments to Rushil Dang were reported at $641. Among 792 Oral & Maxillofacial Surgery profiles paid that year, the median was $184 and the middle half received between $61 and $541.

Show as a table
Year Rushil Dang Oral & Maxillofacial Surgery median Middle half National median
2019 $559 $178 $56–$584 $163
2020 $350 $106 $38–$316 $114
2021 $18,922 $165 $57–$511 $132
2022 $11,652 $173 $63–$494 $149
2023 $0 $184 $62–$521 $160
2024 $1,518 $197 $65–$603 $164
2025 $641 $184 $61–$541 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. KLS-Martin L.P. $30,000 8 payments
  2. Stryker Corporation $1,694 14 payments
  3. Straumann USA LLC $310 3 payments
  4. Zimmer Biomet Holdings, Inc. $295 9 payments
  5. Medical Device Business Services, Inc. $283 3 payments
  6. AxoGen $279 3 payments
  7. Urgo Medical North America, LLC $210 1 payment
  8. Nobel Biocare USA $148 1 payment
  9. Access Pro Medical, LLC $147 1 payment
  10. Medtronic, Inc. $144 1 payment
  11. Other $134 4 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Grant $30,000 8 payments
  2. Food and Beverage $1,717 29 payments
  3. Travel and Lodging $1,047 6 payments
  4. Education $783 4 payments
  5. Gift $95 1 payment
Products named General payments · program years 2019–2025
  1. NA $1,183 9 payments
  2. UNIVERSAL MANDIBLE $339 1 payment
  3. VASHE WOUND SOLUTION 250 ML (8.5 FL OZ) FLIP TOP CAP $210 1 payment
  4. Diem2 $155 6 payments
  5. Matriderm $147 1 payment
  6. PTEYE PARATHYROID DETECTION SYSTEM $144 1 payment
  7. Avance Nerve Graft $127 2 payments
  8. TRUMATCH $92 3 payments
  9. PATIENT-FITTED TMJ RECONSTRUCTIVE PROSTHESIS SYSTEM $90 2 payments
  10. Revitalize $75 1 payment
  11. Other $426 14 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 3 drugs

Part D claims

50

Median for Oral Surgery (Dentist only): 288

Drug cost

$616

Median for Oral Surgery (Dentist only): $1,122

Branded share of claims

22%

Median for Oral Surgery (Dentist only): 18.4%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Dexamethasone Generic 16 $370
Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav Brand 11 $177
Chlorhexidine Gluconate Generic 23 $69

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 5,440 Part D prescribers listed as Oral Surgery (Dentist only); they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 21 billing codes

Paid by Medicare

$7,498

Medicare's payments for the services billed

Medicare patients

32

Average age 69

Services billed

59

16 women, 16 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 34%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

48 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Oral & Maxillofacial Surgery in Michigan

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record